PAHCPhibro Animal Health Corporation

1. Aug 26, 2026Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance.Earnings release · press release
2. Jul 28, 2026On July 28, 2026, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.Other event · Form 8-K
3. Jun 26, 2026On June 25, 2026, in connection with Daniel (Dani) Bendheim’s appointment to the role of Chief Executive Officer and President of the Company effective July 1, 2026 (the “Effective Date”), the Compensation Committee of the Board of Directors of Phibro Animal Health Corporation (the “Company”) approved (i) the …Director or officer change · Form 8-K
4. May 6, 2026Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance.Earnings release · press release
5. May 5, 2026On May 5, 2026, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026.Other event · Form 8-K
6. Apr 30, 2026On April 28, 2026, Phibro Animal Health Corporation (the “Company”) entered into Amendment No. 1 to its Credit Agreement (“Amendment No. 1”) with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer, and each lender from time to time party thereto, which amends the …Material agreement entered · Form 8-K
7. Apr 27, 2026Phibro Animal Health Corporation Announces Regulatory Framework.Regulation FD disclosure · press release
8. Apr 14, 2026On April 13, 2026, Ms. Joyce J. Lee, a member of the Board of the Directors (the “Board”) of Phibro Animal Health Corporation (the “Company”), informed the Company that she intends to resign from her position as Director of the Company effective April 15, 2026.Director or officer change · Form 8-K
9. Feb 4, 2026Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance.Earnings release · press release
10. Feb 3, 2026On February 3, 2026, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026.Other event · Form 8-K
11. Dec 18, 2025On December 18, 2025, Phibro Animal Health Corporation (“Phibro” or the “Company”) announced that Jack C. Bendheim, the current Chairman of the Board of Directors of the Company (the “Board”), Chief Executive Officer and President, will resign from his position as Chief Executive Officer and President, effective July …Director or officer change · Form 8-K
12. Nov 5, 2025On November 4, 2025, the Corporation held its annual meeting of stockholders (the “Meeting”)Earnings release · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.